Over-the-Counter Drugs Stocks
Non-prescription pharmaceutical providers and consumer health manufacturers operate at the intersection of retail convenience and clinical efficacy, capturing recurring revenue through high-volume, brand-loyal wellness products.
As of Oct 23, 2026, Over-the-Counter Drugs has 12 US-listed companies worth $87.9B combined. The median member moved -4.2% over the past week; KVUE led at +3.5% and COSM trailed at -21.2%.
Companies in Over-the-Counter Drugs
- HLN – Haleon plc, $45.6B
- KVUE – Kenvue Inc., $37.6B
- PBH – Prestige Brand Holdings Inc, $2.4B
- PRGO – Perrigo Company PLC, $2.3B
- COSM – Cosmos Health Inc., $33.3M
- CABR – Caring Brands, Inc. Common Stock, $13.4M
- IMRN – Immuron Ltd ADR, $9.4M
- TKLF – Tokyo Lifestyle Co., Ltd., $8.8M
- SNOA – Sonoma Pharmaceuticals Inc, $5.8M
- DRMA – Dermata Therapeutics Inc, $5.6M
- HKPD – Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares, $5.5M
- PTPI – Petros Pharmaceuticals Inc, $127,116